IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
46 hedge funds and large institutions have $103M invested in Ibere Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.25M | |
| 2 | +$1.76M | |
| 3 | +$1.1M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$981K |
Top Sellers
| 1 | -$5.39M | |
| 2 | -$1.96M | |
| 3 | -$1.13M | |
| 4 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$458K |
| 5 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
-$224K |